Silhouette

Martin F Haslanger

Apex Therapeutics, Inc.

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
Novel Therapeutic Strategy for Refractory and Relapse Childhood Acute Leukemia
Apex Therapeutics, Inc.
Principal Investigator
HHS 1 $240K 07/01/13 06/30/14
Redox protein APE1/Ref-1 as a target for age-related macular degeneration (AMD)
Apex Therapeutics, Inc.
Principal Investigator
HHS 1 $225K 09/30/09 06/29/11